Agios Pharmaceuticals, Inc. (AGIO) Q3 2022 Earnings Call Transcript

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q3 2022 Earnings Conference Call November 3, 2022 8:00 AM ET

Company Participants

Holly Manning - Investor Relations
Brian Goff - Chief Executive Officer
Sarah Gheuens - Chief Medical Officer and Head, Research and Development
Richa Poddar - Chief Commercial Officer
Cecilia Jones - Chief Financial Officer

Conference Call Participants

Marc Frahm - Cowen
Mark Breidenbach - Oppenheimer
Andy Berens - SVB
Andrea Tan - Goldman Sachs
Danielle Brill - Raymond James

Operator

Good day and thank you for standing by and welcome to Q3 2022 Agios Pharmaceuticals, Inc. Earnings Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like to hand the conference over to your speaker today, Holly Manning. Please go ahead.

Holly Manning

Thank you, operator. Good morning, everyone, and welcome to Agios’ third quarter 2022 conference call. You can access slides for today’s call by going to the Investors section of our website, agios.com. With me on the call today with prepared remarks are Brian Goff, our Chief Executive Officer; Dr. Sarah Gheuens, our Chief Medical Officer and Head of Research and Development; Richa Poddar, our Chief Commercial Officer; and Cecilia Jones, our Chief Financial Officer.

Before we get started, I would like to remind everyone that some of the statements we make on this call will include forward-looking statements. Actual events and results could differ materially from those expressed or implied by any forward-looking statements as a result of various risks, uncertainties and other factors, including those set forth in our most recent filings with the SEC and any other future filings that we may make with the SEC.

With that, I will turn the call over to Brian.

Brian Goff

Thanks, Holly and good morning, everyone. It’s a privilege to join you today on my first